MarginsXMarginsX
Home › Canada › TSX stocks › CRRX

CareRx Corporation (TSX: CRRX)

CRRX trades on the Toronto Stock Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$3.22
+2.88% on the day
Market cap (C$)
C$213.7M
TMX list, October 31, 2026
Market cap (US$)
US$149.9M
Micro cap at 1.4257 C$/US$
1-year return
0.0%
-15.7% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for CRRX.TO, last bar 2026-11-13, computed by MarginsX.

Profile

FieldValue
TickerCRRX on the Toronto Stock Exchange
Yahoo symbolCRRX.TO
SectorLife Sciences
HeadquartersOntario
Listed2009-09-01
Listing typeTSXV Grad
Shares outstanding63,409,019
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIKNo SEC filer matched on exact name with a Canadian address or US interlisting
WebsiteNo company website on record

Returns

WindowReturn
1 day+2.9%
1 week+3.9%
1 month-3.0%
3 months-1.5%
6 months-7.5%
Year to date-15.7%
1 year0.0%
From 52-week high-18.5%
52-week rangeC$3.05 to C$3.95

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

72 documents in 3 types. Each title links to the document at its source.

Interim financial statements (7)

DocumentTypeFiled
Aug 28, 2018 Q2
Period Q2 2018
Interim financial statements2018-08-28
Dec 28, 2019 Annual Filings
Period Q4 2019
Quarterly report to shareholders2019-12-28
Jul 28, 2019 Q2
Period Q2 2019
Quarterly report to shareholders2019-07-28
Mar 28, 2019 Q1
Period Q1 2019
Quarterly report to shareholders2019-03-28

MD&A (22)

DocumentTypeFiled
Mar 4, 2025 Annual Filings
Period Q4 2025
MD&A (annual)2025-03-04
Dec 5, 2024 Annual Filings
Period Q4 2024
MD&A (annual)2024-12-05
Mar 7, 2023 Annual Filings
Period Q4 2023
MD&A (annual)2023-03-07
Mar 9, 2022 Annual Filings
Period FY2022
MD&A (annual)2022-03-09

Other (43)

Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
TSNDTerrAscend Corp.TSXC$204.1M-20.6%-36.5%
MSCLSatellos Bioscience Inc.TSXC$202.4M-4.0%+14.7%
AIDXHealWELL AI Inc.TSXC$201.6M-16.7%-49.6%
LOVECannara Biotech Inc.TSXC$198.5M-3.8%+23.0%
CRDLCardiol Therapeutics Inc.TSXC$197.0M-14.0%0.0%

The app has the price chart, every filing, private raises and the full peer set for CRRX.

Open in the app